Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kairos Ventures is a venture capital firm founded to support and commercialize scientific discoveries into viable businesses. Operating from regional offices in Pasadena, New York, Washington D.C., and Austin, it manages a portfolio of over 30 active companies. The firm typically invests between $150,000 and $20 million, focusing on early-stage ventures.
Kairos Ventures invests in early-stage companies primarily within the life sciences and physical sciences sectors. The firm targets ideas and patents emerging from leading universities and scientists, making investments that range from $150,000 to $20 million based on the venture's development stage and capital needs.
Notable companies in Kairos Ventures' portfolio include 1200 Pharma, which enhances drug discovery processes; Actinia, developing radiation detection solutions; and Actuate Therapeutics, focusing on clinical-stage therapeutics for high-impact cancers. Other significant firms include Clearsense, a cloud-based healthcare data platform, and Foldax, known for synthetic polymer heart valves.
Submit your pitch through their form at kairosventures.com/contact or email info@kairosventures.com with your deck.
As of March 2026: Kairos Ventures has been actively promoting its portfolio companies, highlighting significant advancements and partnerships through blog posts and updates.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.